ARCHIVES

ODAC Votes Against Adria’s Chemoprotector, Okays Leustatin

This article is from The Cancer Letter archive.

Vol. 18 No. 27 | July 3, 1992

Download PDF Visit The Full Archive

Related Articles

What Should NCI Do When Center Directors Leave? Kimes Asks

July 24, 1992

In Brief: Julie Vose Was Elected President of the American Society of Clinical Oncology

January 3, 2014

Senate Report Calls For Review Of Progress In Cancer Program Restores Prevention And Control Funding

September 18, 1992

DCT Board Pediatric Phase 1 Studies, Effort to Assess Obstacles To Clinical Trials

July 6, 1984

PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III

November 28, 2014

NCI’s caBIG to Expand For Clinical Informatics Projects.

January 26, 2007